Chemed (CHE)
(Delayed Data from NYSE)
$549.27 USD
+8.30 (1.53%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $548.74 -0.53 (-0.10%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth A Momentum B VGM
Balance Sheet
Fiscal Year End for Chemed Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 264 | 74 | 33 | 163 | 6 |
Receivables | 182 | 139 | 137 | 127 | 144 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 12 | 10 | 10 | 7 | 7 |
Other Current Assets | 43 | 49 | 50 | 33 | 33 |
Total Current Assets | 501 | 273 | 230 | 329 | 191 |
Net Property & Equipment | 204 | 200 | 194 | 188 | 176 |
Investments & Advances | 106 | 93 | 99 | 89 | 77 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 675 | 681 | 687 | 697 | 704 |
Deposits & Other Assets | 56 | 60 | 8 | 9 | 9 |
Total Assets | 1,668 | 1,442 | 1,343 | 1,435 | 1,268 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 64 | 42 | 73 | 54 | 51 |
Current Portion Long-Term Debt | 0 | 5 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 153 | 150 | 152 | 157 | 128 |
Income Taxes Payable | 7 | 0 | 0 | 9 | 0 |
Other Current Liabilities | 49 | 61 | 39 | 43 | 44 |
Total Current Liabilities | 312 | 297 | 302 | 299 | 262 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 134 | 131 | 122 | 109 | 95 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 93 | 185 | 0 | 90 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 13 | 12 | 10 | 26 | 8 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 560 | 643 | 719 | 534 | 542 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 37 | 37 | 37 | 36 | 36 |
Capital Surplus | 1,341 | 1,150 | 1,044 | 961 | 861 |
Retained Earnings | 2,447 | 2,198 | 1,970 | 1,724 | 1,426 |
Other Equity | 2 | 2 | 2 | 2 | 2 |
Treasury Stock | 2,720 | 2,588 | 2,430 | 1,823 | 1,598 |
Total Shareholder's Equity | 1,108 | 799 | 623 | 901 | 727 |
Total Liabilities & Shareholder's Equity | 1,668 | 1,442 | 1,343 | 1,435 | 1,268 |
Total Common Equity | 1,108 | 799 | 623 | 901 | 727 |
Shares Outstanding | 15.00 | 14.80 | 15.70 | 15.90 | 16.00 |
Book Value Per Share | 73.86 | 53.97 | 39.70 | 56.68 | 45.41 |
Fiscal Year End for Chemed Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 313 | 264 | 173 | 160 |
Receivables | NA | 177 | 182 | 168 | 120 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 11 | 12 | 13 | 12 |
Other Current Assets | NA | 38 | 43 | 41 | 45 |
Total Current Assets | NA | 540 | 501 | 395 | 337 |
Net Property & Equipment | NA | 203 | 204 | 205 | 208 |
Investments & Advances | NA | 118 | 106 | 104 | 100 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 680 | 675 | 678 | 676 |
Deposits & Other Assets | NA | 56 | 56 | 57 | 57 |
Total Assets | NA | 1,728 | 1,668 | 1,562 | 1,505 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 56 | 64 | 57 | 41 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 119 | 153 | 143 | 138 |
Income Taxes Payable | NA | 27 | 7 | 5 | 0 |
Other Current Liabilities | NA | 40 | 49 | 55 | 85 |
Total Current Liabilities | NA | 282 | 312 | 297 | 302 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 142 | 134 | 133 | 136 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 13 | 13 | 13 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 544 | 560 | 543 | 553 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 37 | 37 | 37 | 37 |
Capital Surplus | NA | 1,399 | 1,341 | 1,254 | 1,240 |
Retained Earnings | NA | 2,506 | 2,447 | 2,363 | 2,294 |
Other Equity | NA | 2 | 2 | 2 | 2 |
Treasury Stock | NA | 2,761 | 2,720 | 2,637 | 2,622 |
Total Shareholder's Equity | NA | 1,184 | 1,108 | 1,019 | 952 |
Total Liabilities & Shareholder's Equity | NA | 1,728 | 1,668 | 1,562 | 1,505 |
Total Common Equity | 0 | 1,184 | 1,108 | 1,019 | 952 |
Shares Outstanding | 15.10 | 15.10 | 15.00 | 15.00 | 15.00 |
Book Value Per Share | 0.00 | 78.38 | 73.86 | 67.95 | 63.47 |